SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 22, 15:33
3245.00
46.35 (1.45%)
VOLUME 42,510
LIVE
NSE
Dec 22, 15:31
3237.90
38.45 (1.2%)
VOLUME 231,292
Earnings News on Dr Reddys Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Likely to file 2 NDAs worth $100 m each soon: Dr Reddy's 

4.51 pm | 29 Oct 2014 |  Source: CNBC-TV18

Discussing the company’s results, GV Prasad co-chairman and CEO, DRL, said the quarter has been a flattish one on the back of high R&D expenses. He ...

Dr Reddy's Q2: Revenue hit by high expenditure, says expert 

1.21 pm | 29 Oct 2014 |  Source: CNBC-TV18

Dr Reddy's Laboratories reported a fall of 16.8 percent in its second quarter consolidated net profit to Rs 574 crore against Rs 690.2 crore in the ye...

Dr Reddy's Labs Q2 disappoints, net falls 17% to Rs 574 cr 

12.39 pm | 29 Oct 2014 |  Source: Moneycontrol.com

Consolidated operating profit during the quarter declined 12.2 percent year-on-year to Rs 646.5 crore and margin dropped 400 basis points to 18 percen...

US core business continues to be a drag for Ranbaxy: CIMB 

9.05 am | 29 Oct 2014 |  Source: CNBC-TV18

Prakash Agarwal, Equity Analyst, CIMB has a hold rating on Ranbaxy with target price of Rs 630/share. ...

Dr Reddy's Labs Q2 profit may fall 22% to Rs 537 cr: Poll

5.16 pm | 28 Oct 2014 |  Source: CNBC-TV18

Revenue is likely to increase 10.3 percent to Rs 3,702 crore in the quarter ended September 2014 compared to Rs 3,357 crore in same quarter last year ...

How did first quarter earnings look? 'Good but not great'

4.55 pm | 18 Aug 2014 |  Source: Moneycontrol.com

As the earnings season winds up and most of India’s notable corporates have posted their quarterly results updates, net profits were slightly ahead ...

Dr Reddy's, Lupin, Glenmark top pharma bets: Nomura 

11.25 am | 31 Jul 2014 |  Source: CNBC-TV18

"We have a buy recommendation on both Sun Pharma and Ranbaxy at this point," Saion Mukherjee, research analyst Nomura said....

DRL to 'perform better than market' this year: CFO 

6.41 pm | 30 Jul 2014 |  Source: Moneycontrol.com

In an interview with CNBC-TV18’s Ekta Batra and Archana Shukla, DRL CFO Saumen Chakraborty discussed the company’s earnings and the outlook going ...

How Angel Broking is reading Dr Reddy's Q1FY15 earnings 

4.57 pm | 30 Jul 2014 |  Source: CNBC-TV18

DRL met street expectations with the consolidated net profit rising 52.4 percent on yearly basis to Rs 550 crore driven by strong growth in US sales a...

Dr Reddy's Q1 profit up 52% on strong North America sales 

2.21 pm | 30 Jul 2014 |  Source: Moneycontrol.com

Consolidated revenue grew 23.6 percent to Rs 3,517 crore in the quarter ended June 2014 compared to Rs 2,845 crore in same quarter last year....

Dr Reddy's Lab Q1 PAT may rise 16% at Rs 419cr: ICICIdirect

11.57 am | 30 Jul 2014 |  Source: Moneycontrol.com

Revenue is expected to decrease by 4.6 percent Q-o-Q (up 16.8 percent Y-o-Y) to Rs 3321.6 crore, according to ICICIdirect.com....

Dr Reddy's Labs Q1 profit seen up 54% to Rs 557.5 cr: Poll 

10.21 am | 30 Jul 2014 |  Source: CNBC-TV18

According to CNBC-TV18 poll estimates, analysts expect profit after tax of the company to increase by 54.4 percent year-on-year to Rs 557.5 crore and ...

Dr Reddy's Q1 net may rise 42% at Rs 513 cr: P Lilladher

9.28 am | 30 Jul 2014 |  Source: Moneycontrol.com

Sales are expected to increase by 3.9 percent Q-o-Q (up 27.1 percent Y-o-Y) to Rs 3617.3 according to Prabhudas Lilladher....

1
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.